Charles River will be exhibiting at this event. Charles River is a leading global supplier of research animal models, including disease and translational models, for use in basic research and nonclinical drug discovery and development.

In addition, our Discovery Services group offers evaluation of test agents in models of type 1 (e.g., streptozotocin-treated rats or mice) and type 2 diabetes. We also perform diet-induced obesity studies, where conventional animals (rats or mice) are fed high-fat diets to induce weight gain, diabetes, high blood pressure, dyslipidemia and other obesity phenotypes. Monitoring of serum lipids, leptin, glucose, insulin, glucagon and vascular complications can be incorporated in the study design for expanded data results.

Our ability to combine standard physiological assays, histopathology, plasma biomarkers and imaging capabilities sets Charles River apart as a premium provider for the assessment of agents intended to treat metabolic disorders. Visit our booth to discuss how we can help you advance your research.

For more information about our participation, please contact us at events@crl.com.